BRNS

BRNS P/E Ratio
P/E Ratio as of Oct 28, 2026: -0.72
Average-0.7200
Median-0.7200
Minimum-0.7200
Maximum-0.7200
-0.72
0.00 (0.00%)past month
The P/E ratio for BRNS is -0.72 as of Oct 28, 2026. This represents a increase of 44.00% compared to its 12-month average P/E ratio of -0.5. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Barinthus Biotherapeutics PLC P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Barinthus Biotherapeutics PLC’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Barinthus Biotherapeutics PLC to industry peers.
Barinthus Biotherapeutics PLC P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Barinthus Biotherapeutics PLC’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Barinthus Biotherapeutics PLC to industry peers.
BRNS P/E Ratio Insights
See Barinthus Biotherapeutics PLC’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in BRNS
Order type
Buy in
Order amount
Est. shares
0 shares
BRNS P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Oct 1, 2026 | — | -0.72 |
| Sep 1, 2026 | $0.765 | -0.75 |
| Aug 3, 2026 | $0.5999 | -0.46 |
| Jul 1, 2026 | $0.641 | -0.50 |
| Jun 1, 2026 | $0.6807 | -0.53 |
| May 1, 2026 | $0.6507 | -0.50 |
| Apr 1, 2026 | $0.5401 | -0.33 |
| Mar 2, 2026 | $0.6118 | -0.32 |
| Feb 2, 2026 | $0.725 | -0.38 |
| Jan 2, 2026 | $0.735 | -0.39 |
BRNS End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | -0.72 | +94.59% |
| 2025 | -0.37 | -54.32% |
| 2024 | -0.81 | — |
FAQs About Barinthus Biotherapeutics PLC (BRNS) P/E ratio
The latest P/E ratio of BRNS is -0.72, as of Oct 28, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Barinthus Biotherapeutics PLC’s last 12-month average P/E ratio is -0.5, compared to its current P/E ratio of -0.72. This reflects a increase of 44.00%.
Barinthus Biotherapeutics PLC’s current P/E ratio of -0.72 is higher than its last 12-month average P/E of -0.5. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Barinthus Biotherapeutics PLC’s average P/E ratio over the last 3 years is -0.49. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Barinthus Biotherapeutics PLC’s average P/E ratio over the last 5 years is -0.3. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.
BRNS P/E Ratio Insights
See Barinthus Biotherapeutics PLC’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in BRNS
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.